JBIO vs NBTX
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jul 08, 2026
JBIO
57.4
AI Score
VS
JBIO Wins
NBTX
52.4
AI Score
Investment Advisor Scores
NBTX
52score
Recommendation
HOLD
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | JBIO | NBTX | Winner |
|---|
Relative Price Performance (Last 90 Days)
JBIO 1M: -1.0%
· 3M: -26.9%
NBTX 1M: -12.3%
· 3M: -26.9%
Current Technical Phase
JBIO
MarkdownSell / avoid
Price below a falling SMA50 (slope -13.5%), weak momentum, RSI 45
NBTX
NeutralHold
Mixed signals - no dominant trend phase, RSI 55
Fundamentals Snapshot
| Metric | JBIO | NBTX |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -5.5 | -196.7 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | -0.8% |
| Gross Margin | — | 1.0% |
| Operating Margin | 0.0% | -3.2% |
| EPS | -1.92 | -1.27 |
| Dividend Yield | — | — |
Frequently Asked Questions
Based on our detailed analysis, JBIO is currently the stronger investment candidate based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.